After Canada legalized recreational cannabis in 2018, many patients left the medical cannabis system. But those who remained used it more actively.
Articles on Marijuana
Displaying 21 - 40 of 202 articles
Moving marijuana to a less restrictive category under the Controlled Substances Act poses benefits and potential risks. But no effective medicine is free from risks.
Colorado and Washington both have legal recreational marijuana. But they regulate growers and dispensaries differently, which has created a David vs. Goliath in the marketplace.
Cannabis and psilocybin – used under supervision – have the potential to work better than current pain treatments, but the research into both has long been hindered by federal legislation.
Policymakers will have to think carefully about pricing, taxation and providing discounts for buying in bulk. Else legalisation may not deliver a substantial tax windfall after all.
THC concentrations in newly available products far exceed those of traditional smoked weed, which can have dangerous unintended consequences in adolescents.
States have experimented with taxes based on price, weight and potency, but competition is heating up as more states legalize and the market matures.
Misleading potency labels can disrupt medical dosages, misguide recreational users and erode trust in the industry.
Hemp flowers and certain cannabis products contain fungal toxins, including Aspergillus and Fusarium, that can exceed acceptable regulatory levels.
New research shows colleges attract interest from higher-caliber students when the schools’ home states allow their citizens to get high.
The plant’s African past provides insight into emerging issues in humanity’s interactions with cannabis.
There were concerns about changes that cannabis legalization might bring. But some trends that were already underway beforehand mostly carried on afterward.
Cannabis growers in the capital report many obstacles, from laws banning the purchase of seeds and artificial lights to the lack of information on growing conditions.
Clinical trials have demonstrated the health benefits of cannabis for certain conditions, but many aren’t testing smoked or vaped forms. Research on cannabis smoke is raising concerns.
Potential long-term, serious consequences of cannabis use include severe cyclical vomiting and a form of cardiomyopathy sometimes called ‘broken heart syndrome.’
Researchers are working to determine how and which cannabis products can help those suffering from chronic pain or serious illness. But science is having a hard time keeping up with the booming market.
Malaysia and Indonesia have been considering whether to follow Thailand in legalizing the use of cannabis, particularly for medical purposes. But another country could serve as a better example.
Studies show that smoking marijuana during pregnancy can lead to premature birth, lower birth weight and psychological problems in the newborn.
Arrest numbers reflect a nearly 40% decline from 2019, but the statistics come with some caveats.
Studies suggest that marijuana and CBD use might help relieve chronic pain while also reducing a patient’s need for opioids.
Top contributors
-
Professor of Operations Research, Brock University
-
Professor of Psychology, Texas State University
-
Distinguished Professor of Pharmacy Practice, University of Connecticut
-
Honorary Fellow, Department of Health Sciences, University of York
-
Emeritus Professor, National Centre for Youth Substance Use Research, The University of Queensland
-
Lecturer, RMIT University
-
Professor of Law, Politics and Society, Drake University
-
Assistant Professor of History, Bard Early College
-
Assistant Professor of Psychiatry and Behavioral Neurosciences, Wayne State University
-
Professor of Population Health, The University of Queensland
-
Associate professor of community health sciences, University of Calgary
-
Emeritus Consultant, St Vincent's Hospital, Darlinghurst
-
Associate Professor of Law, Concordia University School of Law
-
Associate Professor of Sociology, Bentley University
-
Professor & Specialist in Drug Policy, UNSW